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Introduction
Transmissible spongiform encephalopathies (TSEs), also called 
prion diseases, are fatal neurodegenerative disorders including 
Kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-
Scheinker syndrome and fatal familial insomnia in humans, scra-
pie in sheep and goats and bovine spongiform encephalopathy in 
cattle.1,2 The physiological function of the cellular prion protein, 
PrPC, is still elusive but seems linked in various models through 
specific signal transduction pathways with resistance to oxidative 
stress, neuronal outgrowth or cell survival.3 PrPC expression is 
necessary for the development of TSEs as demonstrated by the 
resistance of PrP knock-out animals to prions, while the over-
expression of the protein accelerates the disease.4 In TSEs, this 
Neurodegenerative diseases are often associated with misfolding and deposition of specific proteins in the nervous 
system. The prion protein, which is associated with transmissible spongiform encephalopathies (TSEs), is one of them. 
The normal function of the cellular form of the prion protein (PrPC) is mediated through specific signal transduction 
pathways and is linked to resistance to oxidative stress, neuronal outgrowth and cell survival. In TSEs, PrPC is converted 
into an abnormally folded isoform, called PrPSc, that may impair the normal function of the protein and/or generate toxic 
aggregates. To investigate these molecular events we performed a two-dimensional gel electrophoresis comparison 
of neuroblastoma N2a cells expressing different amounts of PrPC and eventually infected with the 22L prion strain. 
Mass spectrometry and peptide mass fingerprint analysis identified a series of proteins with modified expression. They 
included the chaperones Grp78/BiP, protein disulfide-isomerase A6, Grp75 and Hsp60 which had an opposite expression 
upon PrPC expression and PrPSc production. The detection of these proteins was coherent with the idea that protein 
misfolding plays an important role in TSEs. Other proteins, such as calreticulin, tubulin, vimentin or the laminin receptor 
had their expression modified in infected cells, which was reminiscent of previous results. Altogether our data provide 
molecular information linking PrP expression and misfolding, which could be the basis of further therapeutic and 
pathophysiological research in this field.
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protein is converted into an abnormal isoform named PrPSc 2 that 
accumulates in the central nervous system. This conversion could 
impair PrPC function and/or generate toxic aggregated entities 
like those present in other neurodegenerative disorders. The exact 
involvement of these gain- or loss-of-function mechanisms in 
prion disease pathogenesis is still under debate.
Few proteomics studies have been made in cultured cells 
for investigating molecular pathogenesis of prion disorders.5-8 
Proteomic differential protein expression analysis represents 
however an interesting approach that could complete previous 
genomic studies.9-12 In this article we performed a proteomic 
investigation in an integrated cellular model where both differen-
tial PrPC expression and conversion could be obtained. We relied 
on a PrPC tetracycline-inducible expression system that had been 
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22L prion strain (Fig. 1B). In fact, these cells named: iN2a+22L, 
accumulated significant amount of PrPSc by the third passage fol-
lowing infection and thereafter (up to 20 passages at least, data 
not shown). Interestingly, even though tetracycline compounds 
have been identified as potent anti-prion molecules,18 the amount 
of doxycycline (<0.5 μM) that we used did not prevent in our 
paradigm the accumulation of PrPSc by the cells (Fig. 1B).
Two-dimensional electrophoresis (2DE), selection and iden-
tification of spots. Consecutive lysates of iN2a/iN2a+/iN2a+22L 
cultures were analyzed by 2DE as detailed in the Materials and 
Methods section. An iN2a+22L gel that had the maximum num-
ber of detected spots (Fig. 2) was used as the reference gel when 
using the Melanie 5.0 quantitation software. 544 protein spots 
were detected in this gel (Suppl. Table 1). The matching of this 
gel to the other gels generated raw data, which were the basis 
for the statistical analysis. Spots that had a differential expres-
sion between iN2a, iN2a+ and iN2a+22L cells, as well as spots 
with the same expression localized in different sections of the 
gel—to have spots of references—were selected for mass spec-
trometry identification. A total of 65 protein spots were eventu-
ally identified (Suppl. Table 2 and Table 1). A good correlation 
between the observed and the theoretical pI and molecular 
weight (MW) standard loaded on a gel was observed. For some 
spots the same identification was found corresponding therefore 
to post-translational modified isoforms of the same protein (e.g., 
calreticulin, alpha enolase, lactate dehydrogenase). Classification 
of the identified proteins in different functional blocks6 (Fig. 
3A) revealed, as often found in 2DE studies,15,19,20 that many of 
them belonged to the energetic metabolism (41.5%), followed 
by the protein structure block (27.7%), then translation-mRNA 
processing (13.8%), cytoskeleton (10.7%), proteolysis (6%), 
transport and signal transduction blocks (1.5%). The protein dis-
tribution based on the cellular localization (Fig. 3B) showed, as 
expected for this type of 2DE analysis with urea lysis buffer, that 
58.4% of the proteins were localized in the cytoplasm, 12.3% in 
previously established in the murine neuroblastoma cells N2a.13 
In these inducible cells, named iN2a, PrPC expression levels can 
be controlled by varying the concentration of the tetracycline-
derivative doxycycline acting as effector. For this work, we suc-
cessfully infected these cells with the 22L prion strain. We then 
performed a proteomic two-dimensional gel electrophoresis 
(2DE) comparison of iN2a cells expressing different concentra-
tions of PrPC and either infected or non-infected. Differential pro-
teins were identified by mass spectrometry using a peptide mass 
fingerprint analysis. We could identify several proteins showing 
a modified expression pattern in relation with a PrPC expression 
and/or PrPSc production. Some proteins had an opposite behavior 
in these two situations suggesting a relationship between the 
physiological function of PrPC and its conversion.
Results
Cellular model and PrPC/PrPSc expression. In this study, we 
used a murine neuroblastoma cell line (iN2a) model to inves-
tigate the proteomic consequences of both PrPC expression and 
prion infection. This approach was original as it relied on an inte-
grated cellular model. We paid special attention to analyze cells 
with the same number of sub-passages and cultured in the same 
medium. The tetracycline-inducible expression system respon-
sible here for PrPC overexpression has been used in other 2DE 
proteomics studies of cultured cells where it did not modified 
in a detectable way proteome analysis.17 As expected from previ-
ous work,13 iN2a cultured in the presence of doxycycline (iN2a+) 
showed an increased expression of the three major PrPC bands 
that corresponded to un-, mono- and diglycosylated isoforms of 
the protein (Fig. 1A). A concentration of 200 ng/ml of doxycy-
cline was chosen as it gave a stable and robust PrPC expression 
over repeated passages without modification of the western blot 
profile suggesting that PrPC trafficking/biology was not affected 
by the overexpression. These iN2a+ cells were susceptible to the 
Figure 1. Western blot of the cell extracts after PrPC induction & infection. (A) iN2a cells were cultured for three days with increasing amounts of 
doxycycline. Cells were lysed at 80% of confluence and equal amounts of protein were analyzed by western blotting for PrPC using the antibody 
SAF32. (B) iN2a cultured for three passages with 200 ng/mL of doxycycline (iN2a+) were infected with 22L brain prion homogenate as detailed in the 
Materials and Methods section. After passage 3 or 5, control (Ctrl) and infected cells (22L) were analyzed for PrPC and PrPSc expression (PK- and PK+). 
Infected iN2a+ cells (iN2a+22L) accumulated significant amounts of PrPSc.
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(calreticulin, ATP synthase, lactate dehydrogenase and voltage-
dependent anion-selective channel protein). Importantly, 2DE 
allows the detection of several post-translationally modified iso-
forms of a same protein (after phosphorylation, glycosylation…) 
which expression could then vary differently. The western blot 
analysis of PDIA6, tubulin and vimentin (Fig. 4B) confirmed 
variations observed on 2DE. However, quantitation of the bands 
using the “ImageJ” software (not shown) confirmed the visual 
indication that differences were lower than those observed on 
2DE, especially for tubulin and vimentin. This might be in rela-
tion with the non-linearity of the western blot, as well as, with the 
incapacity of 1D gels to differentiate isoforms as 2DE.
the nucleus, 9.2% in mitochondria and the endoplasmic reticu-
lum, 6% in the cytoplasm and nucleus, 2% on the membrane 
and 1.5% in the mitochondria and nucleus. Identified proteins 
were sorted in eight groups (A to H) based on their differen-
tial expression between iN2a, iN2a+ and iN2a+22L cells (Table 
1). Induction of PrP expression resulted in the decreased expres-
sion of nine proteins (groups A and B). Eight proteins (groups 
C–E) had their expression increased following PrPC overexpres-
sion. Prion infection resulted in the decreased expression of seven 
proteins (groups C and F) and the increased expression of 22 
(groups A, D and G). Among these 22 proteins, 11 increased 
between both iN2a or iN2a+ and infected iN2a+22L. Some of 
these differential expressions were illustrated on the Figure 4A 
Figure 2. 2DE reference gel of iN2a cells. iN2a cell extract were separated using 2DE electrophoresis in a dry strip pH 3–10 for the first dimension, a 
12% SDS-PAGE for the second dimension and silver stained. The identification of proteins, noted with their ID number (Suppl. Tables 1 and 2), was 
performed by peptide mass fingerprints after trypsin digestion and MALDI-TOF on Coomassie or silver stained spots.
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Table 1. Table of identified proteins (spot ID, gene, accession number from UniprotKB database, name and functional group) sorted in eight groups 
(A-H) based on the fold expression ratio iN2a+/iN2a and iN2a+22L/iN2a+
Fold ratio above 1.5 or below -1.5, as well as t-test below 0.05 were used as thresholds for the main proteins studied.
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proteins between brain homogenates of Prnp-/- and Prnp+/+ mice. 
It is however difficult to compare these results with ours as the 
starting material (tissue) and the paradigm (transgenic animals) 
is very different. Finally, the recent study of Moore et al.22 on 
22L-infected brain homogenates did not report protein specifi-
cally associated with PrPSc, suggesting that the selection of our 
candidates related to a metabolic (rather than to a physical) effect 
of this abnormal isoform.
Genomic investigations of cells expressing or not PrPC or after 
prion infection have also been realized.9-12 Comparison of the list 
of differential genes generated in these studies with our differ-
ential proteins was however not informative as it is known that 
such global comparison between genomics and proteomics are 
often disappointing. In addition, a recent work concluded in a 
transcriptional stability of cultured cells upon prion infection,28 
which was in discrepancy with previous works as a possible result 
of differences in experimental stringency of the study design to 
minimize genetic drifts. Genomic investigations have been also 
conducted on brain tissues, for example on cattle during the 
courses of TSEs.29 Comparison with our data was also difficult 
in these cases since these studies evaluated a global pathophysio- 
logical tissue response, and not only that of prion-infected cells.
To evaluate the interest and the relevance of our data, we 
therefore focused on proteins that have already been involved in 
prion biology. A first group of interesting proteins was represented 
Discussion
Proteomic profiling and differential protein expression analyses 
in the prion field were performed in a small number of studies on 
experimental mice and cellular models,5-8,21,22 or on biological flu-
ids in order to find new diagnosis biomarkers.23,24 Work focused 
on identifying PrP partners has been also conducted on purified 
and recombinant molecules.25-27 In a study similar to the one pre-
sented here, Chich et al. compared GT1 cells chronically infected 
with prions to control cells6 while Biaisini and Massignan5,8 
reported interesting results in cultured cells using a 2D proteomic 
approach, but they focused on the impact of mutated PrP rather 
than on its conversion into PrPSc. The number of proteins identi-
fied in common in the different studies is limited which could 
be easily explained by the different cellular models used and by 
distinct paradigms. Importantly in our model, PrPC induction 
and infection was obtained in the same cell clone with a parallel 
analysis of the infected cells, while in Chich et al.6 a comparison 
of control and chronically infected subclones was undertaken. 
Two recent publications analyzed using 2DE gels the influence of 
PrP expression on the proteome of mice21 and cultured cells.7 The 
latter work focused mainly on HEK 293 cells and revealed the 
modification of proteins involved in cell death and in response 
to oxidative stress which was reminiscent of our results. The 
other interesting study did not identify significant differential 
Table 1. Table of identified proteins (spot ID, gene, accession number from UniprotKB database, name and functional group) sorted in eight groups 
(A-H) based on the fold expression ratio iN2a+/iN2a and iN2a+22L/iN2a+
Fold ratio above 1.5 or below -1.5, as well as t-test below 0.05 were used as thresholds for the main proteins studied.
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(this is particularly well documented in yeast).19,20 In 
our study five chaperones (Grp78/BiP, Pdia6, Grp75/
Hspa9, Hsp60/chaperonin, Hsp90B) had their expression 
decreased along with PrPC induction and/or increased fol-
lowing prion infection. This could be in relation with PrPC 
acting as a protector of cellular stress while its misfolding 
conversion could affect this physiological function. Several 
of these chaperones (or their close isoforms) have been already 
by chaperones molecules which have been already identified as 
differential proteins in prion infected cells.30 These molecules 
assist protein folding and handle misfolded polypeptide chains 
by breaking up aggregates and assisting in the refolding process.31 
These proteins were often identified in whole proteome stud-
ies due to their high representation in 2D gels.19,20 The differ-
ential expression of these chaperones was interesting since prion 
conversion is believed to be associated with protein misfolding 
Figure 3. Distribution of the identified proteins per functional blocks (A) and cellular origin (B). (References in Suppl. Table 2.)
Figure 4. Illustration of protein differential expression. (A) Regions of 2DE silver stained gel of the different cell types illustrating the variation of 
calreticulin, ATP synthase, lactate dehydrogenase and voltage-dependent anion-selective channel protein. (B) Western blot detection after 1D gel 
electrophoresis of PDIA6, tubulin beta and vimentin in iN2a, iN2a+ and iN2a+22L. Numbers in parenthesis refer to protein ID numbers (Suppl. Tables 1 
and 3).
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ribonucleoproteins have also been selected as PrP partners and 
some of these proteins had their expression modified in our study 
which was therefore reminiscent of the possible role of the protein 
in RNA trafficking and metabolism.46
Finally, we could observe an increase of the 37 kDa laminin 
receptor (Rpsa) upon infection. This result was consistent with 
previous work47,48 and confirmed the importance of this protein 
that could serve as a prion receptor. The Stress-induced-protein 
1, which was identified as an important partner of PrP49, had its 
expression not modified by either PrP expression or conversion. 
The recent article of Massignan et al.,8 which investigated in 
2DE the molecular alterations induced by expression of mutant 
PrP in N2a cells, identified 11 proteins (out of 42) that were also 
detected in our study. Importantly, many varied in the same man-
ner in both studies (in iN2a: hspa, peripherin, fructose aldolase; 
in iN2a+22L: heterogenius nuclear ribonucleoproteins L, pyru-
vate kinase, enolase, lactate deshydrogenase, voltage-dependant 
anion-selective channel 1). This suggested that the impact of 
mutated PrPs is analogous to that of genuine PrPSc.
Materials and Methods
Culture and prion infection of N2a cells. Generation of the 
murine inducible N2a neuroblastoma cell line (N2a-rtTA-74) 
stably transfected with the tetracycline-controlled transactivator 
and the murine PrP gene under the control of the transactivator-
responsive promoter is described elsewhere.13 To simplify the 
nomenclature, we referred to these cells as “iN2a” in the man-
uscript. They were cultured in DMEM with glutamax, 1 mM 
sodium pyruvate and 1% L-glutamine supplemented with 10% 
heat-inactivated fetal calf serum in an atmosphere of 5% CO
2
, 
95% air and collected at 80% confluence for protein analysis. 
They were cultured in the presence of doxycycline to induce PrPC 
expression. In this case, we referred them as “iN2a+.” Prion infec-
tion of iN2a+ cells was realized using the 22L brain homogenates 
as described before.14 Briefly, subconfluent cultures of iN2a+ 
(induced for 3 passages) were incubated for 4 hr with 0.1% of 
22L brain homogenate diluted in Opti-MEM. Fresh complete 
medium was then added overnight and the cells were split at 1/3 
thereafter. The infected status of the cells was assessed by pro-
teinase K digestion analysis followed by western blot detection 
as described previously.14 22L prion infected iN2a+ cells were 
referred as “iN2a+22L.”
Whole cell extract for 2DE analysis. 2 x 106 cells at 80% 
of confluence were washed twice with PBS containing a cock-
tail of 0.1% protease and 0.1 mmol/L phosphatase inhibitors 
(P8340 and P6508, Sigma respectively) and lysed in 400 μL 
of a 2DE lysis buffer (urea 8 M, thiourea 1 M, Chaps 4.8%, 
dithiothreitol 50 mM). 1% Spermin 24 mM (Fluka 85588) 
was then added for 1 h at room temperature and the sample 
centrifuged 1 h at 20,000 g to precipitate DNA.15 Supernatant 
were then collected and stored at -80°C until use. Protein con-
centration of these lysates was determined using the PlusOne 
2-D Quant Kit (GE Healthcare) following the supplier recom-
mendation. Extracts were prepared at the same time for control 
and infected cells.
identified as important players in prion replication, both in vitro 
and in cell culture. For example, Grp78/BiP bound to mutated 
PrPs and was induced by prion infection.32 Grp58, which cor-
responds to a protein disulfide-isomerase closely related to Pdia6 
(84% of homology), also followed closely the formation of PrPSc 
at all stages of the disease in different brain areas in mice and in 
scrapie infected N2a.32 In addition Grp58 and PrP were shown to 
interact by co-immunoprecipitation and inhibition of the chap-
erone with small interfering RNA led to a significant enhance-
ment of PrPSc toxicity.32 As a matter of fact, the role of heat shock 
proteins (Hsp) in prion response (for our study Hspa5, Hspa9, 
Hsp60, Hsp90B) has been put forward in many studies.32-37 Some 
of these molecules could be associated with PrP26,27 as shown in 
particular for Hsp60,37 or be part of the stress response in rela-
tion with the oxidative stress resulting from prion propagation.38 
We also observed that isoforms of two additional chaperones were 
under-expressed in infected cells: calreticulin and peptidyl-prolyl-
cis-trans isomerase A (Ppia). Calreticulin promotes correct gly-
coprotein synthesis, supports quality control and it was shown 
that it binds a specific hydrophobic polypeptide stretch in PrP.39 
Modification of PrP folding during prion infection could explain 
the low expression of calreticulin, which might be a new therapeu-
tic target of TSEs, by restoring a normal PrP folding along with 
its glycosylation. Ppia, also called cyclophilin A, has been already 
implicated in the metabolism of PrP which contains many proline 
residues. Inhibition of Ppia activity by cyclosporine A resulted in 
the formation of aggresomes containing PrP40 that were associated 
to caspase activation and apoptosis. These structures were also 
detected in prion-infected cells34 and in fact they could be linked 
to the decreased expression of Pdia that we observed. Aggresomes 
with PrP can also result from the inhibition of the proteasome 
which was involved in PrP degradation.41,42 Indeed, we detected 
an increased expression of the alpha 2 major proteasome sub-unit, 
which could be in relation with PrPSc production.
We also noticed that five cytoskeleton proteins: vimentin, 
tubulin beta, actin beta, stomatin-like protein 2 and peripherin 
had their expression decreased following PrPC induction and/
or increased after infection. Vimentin is a member of the inter-
mediate filaments family and a component of aggresome linked 
to prion replication as mentioned above.34 PrP has been also 
identified as an inhibitor of microtubule assembly by inducing 
formation of stable tubulin oligomers43 while actin was involved 
in yeast prion aggregation.44 Modification of cytoskeleton upon 
PrP expression may also reveal a role of the protein in cell 
morphology.45
As often in 2DE differential analysis, proteins involved in 
energy metabolism were detected. In our case, the most remark-
able observation was a clear increase upon prion infection of 
several proteins such as: pyruvate kinase, alpha enolase, aldol-
ase, glyceraldehyde-3-phosphate dehydrogenase, ATP synthase 
or lactate dehydrogenase. Overexpression of these enzymes may 
well relate to the increased requirement of both energy and pro-
tein synthesis pathways upon PrP expression or conversion. It is 
also possible that PrP interacts with some of these proteins and 
in particular with aldolase as detected by far-western immunob-
lotting.25 Interestingly, in the latter study, heterogeneous nuclear 
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concentrator. The resulting pellets were put in 20% formic acid 
solution and desalted using millipore C18 columns.
Analyses were performed using an UltraFlex I MALDI TOF 
mass spectrometer (Bruker Daltonics, Bremen, Germany) in 
the reflectron mode with a 26 kV accelerating voltage and a 50 
ns delayed extraction. Mass spectra were acquired manually or 
automatically using the AutoXecuteTM module of FlexcontrolTM 
(Bruker Daltonics) (laser power ranged from 22–85%, 600 
shots). Spectra were analyzed using FlexAnalysisTM software 
(Bruker Daltonics) and calibrated internally with the autopro-
teolysis peptides of trypsin (m/z 842,51; 1045,56; 2211,10). 
Peptides were selected in the mass range of 900–3,000 Da.
Peptide Mass Fingerprint identification of proteins was per-
formed by searching against the Mus_musculus entries of either 
SwissProt and/or TrEMBL databases (www.expasy.ch) and by 
using the Mascot v2.2 algorithm (www.matrixscience.com) 
with trypsin enzyme specificity and one trypsin missed cleavage. 
Carbamidomethyl was set as fixed cystein modification and oxida-
tion was set as variable methionine modification for searches. A 
mass tolerance of 50 ppm was allowed for identification. Matching 
peptides with one missed cleavage were considered as pertinent 
when there were two consecutives basic residues or when arginine 
and lysine residues were in an acidic context. Mascot scores higher 
than 60 were considered as significant (p < 0.05) for SwissProt 
and TrEMBL databases interrogation. These MALDI-TOF 
analyses were performed on the “Plate-forme de Protéomique 
Fonctionnelle” (CNRS/INSERM, Montpellier, France).
Expasy proteomics server (www.expasy.org), online Mendelian 
Inheritance in Man, OMIMTM, McKusick-Nathans Institute 
for Genetic Medicine, Johns Hopkins (Baltimore, MD) and 
National Center for Biotechnology Information, National Library 
of Medicine (Bethesda, MD), 2000 (www.ncbi.nlm.nih.gov/
omim/) and the Gene Ontology database (www.geneontology.org) 
using the fatigo tool (www.fatigo.org) were also used to complete 
information.
Western blot analysis. Sample migration and transfer on a 
PVDF membrane were performed as recommended by the sup-
plier using the NuPAGE system (including buffers and Bis/Tris 
12% gels) from Invitrogen. PVDF membranes were blocked for 1 
h in 5% (w/v) nonfat dry milk in PBS-T (1% Tween-20 in PBS) 
and incubated for 90 min with 1/500 dilution of the following 
primary antibodies: PDI (SPA 891D, Stressgen), Tubulin beta 
(T8660, Eurogentec) and Vimentin (clone V9, Dako). After sev-
eral washes in PBS-T, the secondary antibody anti-mouse IgG cou-
pled to HRP from Jackson was incubated for 90 min (1/25,000) 
and after washes, the signal was revealed using enhanced chemi-
luminescent (ECL) (SuperSignal West Pico, Ref: 34078) from 
Pierce using a camera system (ChemiDoc XRS from Bio-Rad).
Conclusion
Both increased expression of PrPC and conversion into PrPSc in 
N2a cells induced significant and partially opposite changes in 
the proteome. Among the 65 identified proteins, many chaper-
ones, enzymes of the energetic pathway, as well as cytoskeleton 
proteins had their expression modified. These results were mostly 
2D-Electrophoresis. The following conditions for 2DE 
resulted from a previous study15 and adapted to murine N2a cell 
extract (not shown). For the first dimension, 20 μg of proteins 
per sample were added to 250 μL of rehydration buffer (9.8 M 
urea 4% CHAPS 50 mM DTT and 0.5% IPG buffer 3–10). IPG 
strips (13 cm), covering a pH range from 3–10 were rehydrated 
with this solution during 9 h at 20°C covered by low viscosity 
paraffin oil. For focalization, the following voltage/time profile 
was used: 30 V for 3 h, 200 V for 2 h, 1,000 V for 1 h, 3,000 V 
for 1 h, a gradient between 3,000 V and 8,000 V during 2 h 
and 8,000 V for 7 h. A total of 75,000 v.h was used. Focused 
strips were frozen at -20°C. For the second dimension, strips were 
equilibrated for 30 min in 6 M urea, 30% glycerol, 2% SDS, 50 
mM Tris pH 8.8, 1% DTT and then for an additional 30 min in 
the same solution except that DTT was replaced by 5% iodoacet-
amide. After equilibration, proteins were separated in the second 
dimension by an SDS-PAGE method using 12% acrylamide gel 
with a ratio of acrylamide/bisacrylamide of 37.5:1.
Identification of protein expression and statistical test. Gels 
were stained with a silver nitrate procedure16 and scanned at 300 
dots per inch using the Labscan 3 software (GE Healthcare) 
after a procedure of calibration using the kaleidoscope LaserSoft 
Imaging (Kodak Ref: R020123). Spot detection and quantitation 
were performed with Melanie 5.0 software. The volume of each 
spot (integrated optical density) was calculated as the product of 
spot area and spot intensity. To take into account experimental 
variations, 2DE gels were normalized to the volume of all spots 
detected. Each gel was matched with others using at least ten 
landmarks per pairs and a minimal percentage of matches of 
70% was obtained between each pairs. The reference gel used 
was that of the iN2a+22L cells. The experimental molecular 
weight (MW) and iso-electric point (pHi) were obtained based 
on the migration of a 2D protein standard (Bio-Rad, Richmond, 
CA, USA) spiked into a whole iN2a extract (not shown). Four 
to seven replicates with independent samples were performed to 
ensure reproducibility of the results (Suppl. Table 1). For com-
parison, the iN2a+22L gel was used as reference. Monovariate 
statistical analysis (Mann-Whiteney test) was performed using 
Tanagra software version 1.4.36.
Protein isolation and identification by mass spectrometry. 
Protein spots were excised from either silver or PageBlue stained 
2D gels. In the latter case the gel was ran with 300 μg of pro-
teins. Spots were washed in 15 μL of 100 mM NH
4
HCO
3
 for 
10 min. After addition of 15 μL of acetonitril and incubation for 
10 min, the supernatant was removed and the procedure repeated. 
After 5 min in a centrivap concentrator, spots were re-hydrated 
in 10 μL of trypsin solution (15 ng/μL, Promega) and digested 
overnight at 25°C in 10 μL of 100 mM NH
4
HCO
3
 5 mM 
CaCl
2
 buffer. The tryptic peptides were extracted in a two steps 
procedure: the first step was composed of addition of 10 μL of 
100 mM NH
4
HCO
3
 followed by 10 min of 10 μL acetonitril. 
This step was repeated twice and the supernatants were pooled. 
The second step was an incubation of 10 min with 10 μl of 5% 
formic acid and an addition of 10 μl of acetonitril for 10 min. 
This step was repeated twice and the supernatants were pooled 
with those from the previous step then dried in the centrivap 
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the CNRS. We thank Jacques Grassi and colleagues (CEA 
Saclay, France) for providing anti-prion antibodies and Patrick 
Jouin and colleagues from the “Plate-forme de Protéomique 
Fonctionnelle, IFR3, CNRS-UMR 5203, INSERM-U661” for 
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Note
Supplementary materials can be found at:
www.landesbioscience.com/supplement/Provansal-PRION4-4-
Sup.xls
coherent with previous findings and knowledge of prion biol-
ogy. Finally, we observed a very interesting opposite expression 
variation trend of proteins upon PrPC expression and conversion 
suggesting that the infection rendered PrPC less available for 
molecular partners and/or to fulfill its normal cellular function.
Acknowledgements
This work is supported by grants from the “GIS Infections 
à Prion”, the EU Commission program NEUROPRION 
(FOOD-CT-2004-506579), the DEFRA project SE2002 and 
References
1. Aguzzi A, Glatzel M, Montrasio F, Prinz M, Heppner 
FL. Interventional strategies against prion diseases. Nat 
Rev Neurosci 2001; 2:745-9.
2. Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. 
Prion protein biology. Cell 1998; 93:337-48.
3. Linden R, Martins VR, Prado MA, Cammarota M, 
Izquierdo I, Brentani RR. Physiology of the prion 
protein. Physiol Rev 2008; 88:673-728.
4. Weissmann C, Flechsig E. PrP knock-out and PrP 
transgenic mice in prion research. Br Med Bull 2003; 
66:43-60.
5. Biasini E, Massignan T, Fioriti L, Rossi V, Dossena S, 
Salmona M, et al. Analysis of the cerebellar proteome 
in a transgenic mouse model of inherited prion disease 
reveals preclinical alteration of calcineurin activity. 
Proteomics 2006; 6:2823-34.
6. Chich JF, Schaeffer B, Bouin AP, Mouthon F, Labas V, 
Larramendy C, et al. Prion infection-impaired func-
tional blocks identified by proteomics enlighten the 
targets and the curing pathways of an anti-prion drug. 
Biochim Biophys Acta 2007; 1774:154-67.
7. Ramljak S, Asif AR, Armstrong VW, Wrede A, 
Groschup MH, Buschmann A, et al. Physiological role 
of the cellular prion protein (PrPC): protein profiling 
study in two cell culture systems. J Proteome Res 2008; 
7:2681-95.
8. Massignan T, Biasini E, Lauranzano E, Veglianese P, 
Pignataro M, Fioriti L, et al. Mutant prion protein 
expression is associated with an alteration of the Rab 
GDP dissociation inhibitor alpha (GDI)/Rab11 path-
way. Mol Cell Proteomics 2010; 9:611-22.
9. Fasano C, Campana V, Griffiths B, Kelly G, Schiavo 
G, Zurzolo C. Gene expression profile of quina-
crine-cured prion-infected mouse neuronal cells. J 
Neurochem 2008; 105:239-50.
10. Greenwood AD, Horsch M, Stengel A, Vorberg I, 
Lutzny G, Maas E, et al. Cell line dependent RNA 
expression profiles of prion-infected mouse neuronal 
cells. J Mol Biol 2005; 349:487-500.
11. Satoh J, Kuroda Y, Katamine S. Gene expression 
profile in prion protein-deficient fibroblasts in culture. 
Am J Pathol 2000; 157:59-68.
12. Satoh J, Yamamura T. Gene expression profile follow-
ing stable expression of the cellular prion protein. Cell 
Mol Neurobiol 2004; 24:793-814.
13. Windl O, Lorenz H, Behrens C, Romer A, Kretzschmar 
HA. Construction and characterization of murine neu-
roblastoma cell clones allowing inducible and high 
expression of the prion protein. J Gen Virol 1999; 
80:15-21.
14. Nishida N, Harris DA, Vilette D, Laude H, Frobert Y, 
Grassi J, et al. Successful transmission of three mouse-
adapted scrapie strains to murine neuroblastoma cell 
lines overexpressing wild-type mouse prion protein. J 
Virol 2000; 74:320-5.
15. Roche S, Delorme B, Oostendorp RA, Barbet R, 
Caton D, Noel D, et al. Comparative proteomic 
analysis of human mesenchymal and embryonic stem 
cells: towards the definition of a mesenchymal stem 
cell proteomic signature. Proteomics 2009; 9:223-32.
16. Shevchenko A, Wilm M, Vorm O, Mann M. Mass 
spectrometric sequencing of proteins silver-stained 
polyacrylamide gels. Anal Chem 1996; 68:850-8.
17. Kim S, Lee YZ, Kim YS, Bahk YY. A Proteomic 
approach for protein-profiling the oncogenic ras 
induced transformation (H-, K- and N-Ras) in 
NIH/3T3 mouse embryonic fibroblasts. Proteomics 
2008; 8:3082-93.
18. Forloni G, Iussich S, Awan T, Colombo L, Angeretti 
N, Girola L, et al. Tetracyclines affect prion infectivity. 
Proc Natl Acad Sci USA 2002; 99:10849-54.
19. Petrak J, Ivanek R, Toman O, Cmejla R, Cmejlova J, 
Vyoral D, et al. Deja vu in proteomics. A hit parade of 
repeatedly identified differentially expressed proteins. 
Proteomics 2008; 8:1744-9.
20. Wang H, Hanash S. Electrospray mass spectrometry 
for quantitative plasma proteome analysis. Methods 
Mol Biol 2009; 564:227-42.
21. Crecelius AC, Helmstetter D, Strangmann J, 
Mitteregger G, Frohlich T, Arnold GJ, et al. The brain 
proteome profile is highly conserved between Prnp-/- 
and Prnp+/+ mice. Neuroreport 2008; 19:1027-31.
22. Moore RA, Timmes A, Wilmarth PA, Priola SA. 
Comparative profiling of highly enriched 22L and 
Chandler mouse scrapie prion protein preparations. 
Proteomics 2010;10:2858-69.
23. Brechlin P, Jahn O, Steinacker P, Cepek L, Kratzin H, 
Lehnert S, et al. Cerebrospinal fluid-optimized two-
dimensional difference gel electrophoresis (2-D DIGE) 
facilitates the differential diagnosis of Creutzfeldt-
Jakob disease. Proteomics 2008; 8:4357-66.
24. Huzarewich RL, Siemens CG, Booth SA. Application 
of “omics” to prion biomarker discovery. J Biomed 
Biotechnol 2010; 2010:613504.
25. Strom A, Diecke S, Hunsmann G, Stuke AW. 
Identification of prion protein binding proteins by 
combined use of far-western immunoblotting, two 
dimensional gel electrophoresis and mass spectrometry. 
Proteomics 2006; 6:26-34.
26. Petrakis S, Sklaviadis T. Identification of proteins with 
high affinity for refolded and native PrPC. Proteomics 
2006; 6:6476-84.
27. Giorgi A, Di Francesco L, Principe S, Mignogna G, 
Sennels L, Mancone C, et al. Proteomic profiling 
of PrP27–30-enriched preparations extracted from 
the brain of hamsters with experimental scrapie. 
Proteomics 2009; 9:3802-14.
28. Julius C, Hutter G, Wagner U, Seeger H, Kana V, 
Kranich J, et al. Transcriptional stability of cultured 
cells upon prion infection. J Mol Biol 2008; 375: 
1222-33.
29. Tang Y, Xiang W, Hawkins SA, Kretzschmar HA, 
Windl O. Transcriptional changes in the brain of cattle 
orally infected with BSE precede detection of infectiv-
ity. J Virol 2009; 83:9464-73.
30. Tatzelt J, Zuo J, Voellmy R, Scott M, Hartl U, 
Prusiner SB, et al. Scrapie prions selectively modify the 
stress response in neuroblastoma cells. Proc Natl Acad 
Sci USA 1995; 92:2944-8.
31. True HL. The battle of the fold: chaperones take on 
prions. Trends Genet 2006; 22:110-7.
32. Hetz C, Russelakis-Carneiro M, Walchli S, Carboni 
S, Vial-Knecht E, Maundrell K, et al. The disulfide 
isomerase Grp58 is a protective factor against prion 
neurotoxicity. J Neurosci 2005; 25:2793-802.
33. Wacker JL, Huang SY, Steele AD, Aron R, Lotz GP, 
Nguyen Q, et al. Loss of Hsp70 exacerbates patho-
genesis but not levels of fibrillar aggregates in a mouse 
model of Huntington’s disease. J Neurosci 2009; 
29:9104-14.
34. Kristiansen M, Messenger MJ, Klohn PC, Brandner S, 
Wadsworth JD, Collinge J, et al. Disease-related prion 
protein forms aggresomes in neuronal cells leading to 
caspase activation and apoptosis. J Biol Chem 2005; 
280:38851-61.
35. Gauczynski S, Hundt C, Leucht C, Weiss S. Interaction 
of prion proteins with cell surface receptors, molecular 
chaperones and other molecules. Adv Protein Chem 
2001; 57:229-72.
36. DebBurman SK, Raymond GJ, Caughey B, Lindquist 
S. Chaperone-supervised conversion of prion protein 
to its protease-resistant form. Proc Natl Acad Sci USA 
1997; 94:13938-43.
37. Edenhofer F, Rieger R, Famulok M, Wendler W, Weiss 
S, Winnacker EL. Prion protein PrPc interacts with 
molecular chaperones of the Hsp60 family. J Virol 
1996; 70:4724-8.
38. Milhavet O, Lehmann S. Oxidative stress and the 
prion protein in transmissible spongiform encepha-
lopathies. Brain Res Brain Res Rev 2002; 38:328-39.
39. Sandhu N, Duus K, Jorgensen CS, Hansen PR, Bruun 
SW, Pedersen LO, et al. Peptide binding specificity 
of the chaperone calreticulin. Biochim Biophys Acta 
2007; 1774:701-13.
40. Cohen E, Taraboulos A. Scrapie-like prion protein 
accumulates in aggresomes of cyclosporin A- treated 
cells. EMBO J 2003; 22:404-17.
41. Ma J, Lindquist S. Wild-type PrP and a mutant 
associated with prion disease are subject to retrograde 
transport and proteasome degradation. Proc Natl Acad 
Sci USA 2001; 98:14955-60.
42. Deriziotis P, Tabrizi SJ. Prions and the proteasome. 
Biochim Biophys Acta 2008; 1782:713-22.
43. Nieznanski K, Nieznanska H, Skowronek KJ, Osiecka 
KM, Stepkowski D. Direct interaction between prion 
protein and tubulin. Biochem Biophys Res Commun 
2005; 334:403-11.
44. Ganusova EE, Ozolins LN, Bhagat S, Newnam GP, 
Wegrzyn RD, Sherman MY, et al. Modulation of 
prion formation, aggregation and toxicity by the actin 
cytoskeleton in yeast. Mol Cell Biol 2006; 26:617-29.
45. Martin SF, Herva ME, Espinosa JC, Parra B, Castilla J, 
Brun A, et al. Cell expression of a four extra octarepeat 
mutated PrPC modifies cell structure and cell cycle 
regulation. FEBS Lett 2006; 580:4097-104.
46. Silva JL, Lima LM, Foguel D, Cordeiro Y. Intriguing 
nucleic-acid-binding features of mammalian prion 
protein. Trends Biochem Sci 2008; 33:132-40.
www.landesbioscience.com Prion 301
47. Rieger R, Edenhofer F, Lasmezas CI, Weiss S. The 
human 37 kDa laminin receptor precursor interacts 
with the prion protein in eukaryotic cells. Nat Med 
1997; 3:1383-8.
48. Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, 
Rieger R, et al. The 37 kDa/67 kDa laminin receptor 
acts as the cell-surface receptor for the cellular prion 
protein. EMBO J 2001; 20:5863-75.
49. Lopes MH, Hajj GN, Muras AG, Mancini GL, Castro 
RM, Ribeiro KC, et al. Interaction of cellular prion 
and stress-inducible protein 1 promotes neuritogenesis 
and neuroprotection by distinct signaling pathways. J 
Neurosci 2005; 25:11330-9.
